Bill Crossman is an unlikely candidate to run a pharmaceutical firm.

The 71-year-old Connecticut businessman had spent decades growing a diverse collection of companies making everything from elevators to eco-friendly products. He had never run a drug company — and had little to no experience in the industry.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

  • Hopefully the claims he makes turn out to be true in humans. If it does reach market physicians would likely still provide abusive drugs – look at the slow up take of abuse deterrent opioids (just get the non deterrent generic instead).

Sign up for our Biotech newsletter — The Readout

Your daily guide to what’s new in biotech.